A
Akebia Therapeutics, Inc. (AKBA)
NCM – Real Time Price. Currency in USD
1.18
+0.03 (2.61%)
At close: May 12, 2026, 4:00 PM EDT
1.17
-0.01 (-0.81%)
After-hours: May 12, 2026, 7:44 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
1.18
+0.03 (2.61%)
At close: May 12, 2026, 4:00 PM EDT
1.17
-0.01 (-0.81%)
After-hours: May 12, 2026, 7:44 PM EDT
No Data
There are no news for this stock.
Total debt $217.9M significantly exceeds cash reserves ($164.3M), raising financial stability concerns
Total current assets $243.5M exceed Total current liabilities $173.9M, highlighting excellent liquidity
Debt-to-equity ratio (8.0) far exceeds the industry average, reflecting over-leverage
Interest coverage ratio (-1.0x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$21.3M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.40 | 2.52 | 7.0 | |
| Quick ratio | 1.33 | 1.78 | 7.0 | |
| Debt to Equity | 7.96 | -0.80 | 2.0 | |
| Debt to Assets | 0.60 | 0.73 | 4.0 | |
| Interest coverage | -1.00 | -13.90 | 1.0 | |
| Weighted average score | 4.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 292M | 195M | 160M | 236M | 232M |
| Gross Profit | 205M | 119M | 91M | 195M | 187M |
| Operating Income | -65M | -46M | -50M | 23M | 5M |
| Net Income | -94M | -52M | -69M | -5M | -21M |
| EBITDA | -30M | -4M | -9M | 25M | 7M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -16.3 | N/A | 1.0 |
| Next quarter | -6.81 | N/A | 1.0 |
| Current year | -5.81 | -330 | 1.0 |
| Next year | -21.15 | -116.28 | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -7.07 | 26.05 | 40 | -168.47 | 5.5 |
| Y/Y | -6.6 | -248.12 | -199.99 | -56.32 | 1.0 |
| 3y average | -1.22 | 34.51 | 40.4 | 86.81 | 7.8 |
| 5y average | 1.24 | 39.31 | 45.96 | 40.59 | 8.3 |
| Weighted average score | 5.7 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |